Nelfinavir mesilate or mesylate

Application 6,7-Dimethyl-2,3-di-(2-pyridyl)quinoxaline has been used as an internal standard to investigate the clinical pharmacokinetics of nelfinavir mesylate, a potent inhibitor of HIV-1 protease .

Immunogen Synthetic peptide of human vacuolar protein sorting 4 homolog B (S. cerevisiae) Features and Benefits Evaluate our antibodies with complete peace of mind.

A pre-assembled system that creates a closed single lumen fluid path, designed to minimize blood leakage from the catheter hub, and the potential for contamination and exposure to blood. A second port allows for simultaneous administration of compati

Mouse anti Human CD47 Antibody, Monoclonal (B6H12), could be used for Flow and so on. :Application: Flow: 1.0 μg/100w cells :Protein Function: Has a role in both cell adhesion by acting as an adhesion receptor for THBS1 on platelets, and in the

Menactra Meningitis All SDV, .5mL, 5/pk

Application Negative controls are an essential part of every siRNA experiment, and here we offer two sizes for your convenience. This negative control has been tested in vitro in Human, Mouse, and Rat cells.

InformationNafamostat mesilate (FUT-175) is a syntheticserine proteaseinhibitor, used as an anticoagulant during hemodialysis. Nafamostat mesylate blocks activation of SARS-CoV-2 and is investigated as a new treatment option for COVID-19. Nafamostat

Negative Q Controls for use with SARS-CoV-2 assays

An orally bioavailable inhibitor of the HIV-1 protease (Ki =2 nM) that is used in combination with HIV reverse transcriptase inhibitors for the treatment of HIV infection.

An orally bioavailable inhibitor of the HIV-1 protease (Ki =2 nM) that is used in combination with HIV reverse transcriptase inhibitors for the treatment of HIV infection.

An orally bioavailable inhibitor of the HIV-1 protease (Ki =2 nM) that is used in combination with HIV reverse transcriptase inhibitors for the treatment of HIV infection.

An orally bioavailable inhibitor of the HIV-1 protease (Ki =2 nM) that is used in combination with HIV reverse transcriptase inhibitors for the treatment of HIV infection.